Japan
CROSS SYNC, Inc. is a medtech AI startup officially certified by Yokohama City University. Founded in 2019 by Dr. Takaki, an intensivist driven by the mission to eliminate preventable deaths, motivated by his traumatic experience during medical residency. The company's focus is on providing technologies that cover expertise in clinical environments, especially in intensive care units (ICU).
Their flagship product, iBSEN, is a medical data analytics software that enables hospital Intensive Care Units to automate the monitoring of patient vitals and motions, ensuring healthcare professionals can provide high-quality care through real-time actionable intelligence to reduce deterioration and possible death.
As of 16 February 2023, CROSS SYNC, Inc. secured a Series A investment from IT-Farm, marking a significant milestone in their journey towards revolutionizing medtech AI. With their headquarters in Japan, the company is poised to make a substantial impact in the healthcare industry through their innovative solutions.
